Monitoring Changes in Intracellular Reactive Oxygen Species Levels in Response to Histone Deacetylase Inhibitors
Author:
Mustafa Al-Hassan M.ORCID,
Ashry RamyORCID,
Krämer Oliver H.ORCID
Reference31 articles.
1. Li Z, Xu X, Leng X, He M, Wang J, Cheng S et al (2017) Roles of reactive oxygen species in cell signaling pathways and immune responses to viral infections. Arch Virol 162(3):603–610. https://doi.org/10.1007/s00705-016-3130-2
2. Thannickal VJ, Fanburg BL (2000) Reactive oxygen species in cell signaling. Am J Phys Lung Cell Mol Phys 279(6):L1005–L1L28. https://doi.org/10.1152/ajplung.2000.279.6.L1005
3. Zhang J, Wang X, Vikash V, Ye Q, Wu D, Liu Y et al (2016) ROS and ROS-mediated cellular signaling. Oxidative Med Cell Longev 2016:4350965. https://doi.org/10.1155/2016/4350965
4. Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G et al (2020) ROS in cancer therapy: the bright side of the moon. Exp Mol Med 52(2):192–203. https://doi.org/10.1038/s12276-020-0384-2
5. Ray PD, Huang B-W, Tsuji Y (2012) Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24(5):981–990